Radioactive Diagnostic Agent Market: Global Industry Size, Share, Growth, Forecast 2016 - 2023
Latest
industry research report on: Global Radioactive Diagnostic Agent
Market | Industry Size, Share, Research, Reviews, Analysis,
Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Radioactive agents are the
nucleus of an unstable atom which emits radiations such as alpha,
beta, gamma and X-rays and loses its energy. Radioactive diagnostic
agents are mainly used to detect abnormalities and malfunction of
specific tissue or organ in a body. Diagnostic techniques include
medicine which are combined with radiotracers, which emit gamma rays
from radiotracers within the body. These tracers are generally short
half-lives isotopes linked to chemical compounds which goes through
specific physiological processes. Radioactive agents are important in
the diagnosis as well as therapy of specific disease or defect in the
body. Such radioactive agents are majorly used in cancer therapy.
Moreover, number of biological studies are carried out with help of
radioisotopes such as molecular biology, cell biology and structural
biology. Radioactive agents are generally of two types: radioisotopes
and radiotracers. Radioactive diagnostic agent are extremely helpful
in the detection of internal organ complications. Radioisotopes are
also widely used in scientific research laboratories, to determine
metabolic processes in small animals as well as to study the
pharmacokinetics of drugs.
Complete Report Details @
https://www.marketresearchreports.biz/reports/1357545/radioactive-diagnostic-agent-global-market-research-reports
Global
radioactive diagnostic agent market has been segmented by product,
applications, end users and geography. In terms of product,
radioactive diagnostic agent has been categorized into radioisotopes
and radiotracers. Based on the application, radioactive diagnostic
agent market are segmented into single-photon emission computed
tomography (SPECT) and Positron emission tomography (PET).
Single-photon emission computed tomography is further sub-segmented
into tumor imaging, Infection imaging, thyroid imaging, bone
scintigraphy, internal organ functions, cardiac function and brain
imaging. Positron emission tomography is also further sub-segmented
into oncology, brain function, heart function, drug development,
pharmacokinetics studies, Infectious diseases detection, neuroimaging
and musculo-skeletal imaging. Moreover there are various other
applications of the diagnostic agents which depends on the disease
and illness of the patient. Majorly radioactive agents are used to
detect tumor and cancerous cells and majorly used with positron
emission tomography (PET). The end user for the radioactive
diagnostic agent market include hospitals, nursing facilities, long
term care centers, diagnostic imaging centers, pharmaceutical
companies, research centers and many others.
Geographically,
radioactive diagnostic agent market is classified into five regional
markets, namely, North America (United States and Canada), Europe
(Germany, France, United Kingdom, etc.) and Asia-Pacific (Australia,
China, Japan, India, etc.), Latin America and rest of the world.
North America was observed as the largest market, in terms of revenue
for radioactive diagnostic agents. North America was followed by
Europe and is expected to register higher growth. Emerging markets
such as Asia Pacific, Latin America and the Middle East and Africa
are expected to record robust growth during the forecast period
2016-2024 due to growing health care industry, and aging population
which consequently would lead to increased patient population in
these countries. India, China and Brazil are expected to drive strong
growth among the emerging countries, owing to increasing investments
by government bodies in order to enhance healthcare facilities.
In
addition, there are a number of factors that would affect the growth
of radioactive diagnostic agent market such as technological
advancement, awareness about health in developing countries and
increase in the number of cancer patients. The market is also
witnessing certain restraints, such as stiff competition among
existing radioactive diagnostics agent manufacturers, government
regulations for reduction of overall healthcare cost and subsequent
upswing in bulk purchasing through INHs and GPOs (Group Purchasing
Organizations)
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1357545
The major players operating in
this market include GE healthcare, Cardinal Health, Mallinckrodt, Eli
Lilly and Company, Zevacor Molecular, Navidea Biopharmaceuticals,
Advanced Accelerator Applications, Blue Earth Diagnostics Limited,
Bracco Diagnostic Inc., Lantheus Medical Imaging, Inc., Jazz
Pharmaceuticals and many others significant players present
worldwide.
The report offers a
comprehensive evaluation of the market. It does so via in-depth
insights, understanding market evolution by tracking historical
developments, and analyzing the present scenario and future
projections based on optimistic and likely scenarios. Each research
report serves as a repository of analysis and information for every
facet of the market, including but not limited to: Regional markets,
technology developments, types, applications, and the competitive
landscape.
The study is a source of
reliable data on:
Key market segments and
sub-segments
Evolving market trends and
dynamics
Changing supply and demand
scenarios
Quantifying market
opportunities through market sizing and market forecasting
Tracking current
trends/opportunities/challenges
Competitive insights
Opportunity mapping in
terms of technological break throughs
The regional analysis
covers:
North America (U.S. and
Canada)
Latin America (Mexico,
Brazil, Peru, Chile, and others)
Western Europe (Germany,
U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands,
Luxembourg)
Eastern Europe (Poland,
Russia)
Asia Pacific (China, India,
Japan, ASEAN, Australia and New Zealand)
Middle East and Africa
(GCC, Southern Africa, North Africa)
TMR estimates the market size
of various sectors using a combination of available data on the
number and revenue of companies within each sub-sector and tiers of
companies. The basic components used to determine market size and
forecast for a specific product area are not only limited to
supply-side data, but are also related to demand, industry trends,
and the economic outlook. All the above data points are utilized to
generate a statistical model targeting the sector marketplace. More
than 300 TMR analysts across the world integrate these elements into
a framework to determine the subsector market size for a base year
and then forecast growth within each market.
TMR regularly interviews
technology and business professionals as an ongoing effort to track
the latest developments within each sector. These continuous surveys
are stratified by company size and industry segment and weighted to
reflect the global market place. All data are collected on an
ongoing effort through a structured questionnaire rolled over the web
or conducted via telephones. This provides the TMR team opportunities
to request for detailed question sets, complex skip patterns, and
real-time calculations, which assists respondents in answering
questions involving numbers and percentages. Respondents, who are
interviewed as experts, are screened and qualified based on certain
criteria in addition to their decision-making authority and the scope
of activity within their organizations.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment